Eton Pharmaceuticals (ETON) Other financing activities (2018 - 2023)
Eton Pharmaceuticals' Other financing activities history spans 4 years, with the latest figure at -$1000.0 for Q4 2023.
- On a quarterly basis, Other financing activities changed N/A to -$1000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $180000.0, a N/A change, with the full-year FY2024 number at $180000.0, changed 0.0% from a year prior.
- Other financing activities hit -$1000.0 in Q4 2023 for Eton Pharmaceuticals, down from $181000.0 in the prior quarter.
- Over the last five years, Other financing activities for ETON hit a ceiling of $1.0 million in Q3 2021 and a floor of -$1000.0 in Q4 2023.
- Historically, Other financing activities has averaged $573214.3 across 4 years, with a median of $605000.0 in 2019.
- Biggest five-year swings in Other financing activities: rose 5.8% in 2020 and later surged 84.38% in 2021.
- Tracing ETON's Other financing activities over 4 years: stood at $501000.0 in 2019, then surged by 54.29% to $773000.0 in 2020, then increased by 11.64% to $863000.0 in 2021, then plummeted by 100.12% to -$1000.0 in 2023.
- Business Quant data shows Other financing activities for ETON at -$1000.0 in Q4 2023, $181000.0 in Q1 2023, and $863000.0 in Q4 2021.